Clinical Trials
6 trialsNCT01159067 2019-06-18
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
City of Hope Medical Center
Phase 2 Terminated
NCT00602446 2017-12-28
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT03141398 2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn
NCT01965171 2017-05-16
Transfusional Iron Overload Among Leukemia Survivors
St. Jude Children's Research Hospital
Completed
NCT00658411 2013-04-09
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
Dana-Farber Cancer Institute
Phase NA Terminated
NCT00954720 2013-02-28
Observational Study of Iron Overload in Stem Cell Transplantation
Dana-Farber Cancer Institute
Completed